Latest News and Press Releases

Stockholm - Tele2 AB, ("Tele2"), (Stockholm Stock Exchange: TEL2 A and TEL2 B), today announced that it has sold its Polish operation to Netia. Netia will pay in cash approximately SEK 300 million on...

Stockholm - Tele2 AB ("Tele2"), (Stockholmsbörsen: TEL2 A och TEL2 B), meddelade idag att företaget har sålt verksamheten i Polen till Netia. Netia kommer att betala kontant cirka 300 miljoner kronor...

Share capital increase as a result of employee stock option exercise pursuant to Intrum Justitia's Employee Stock Option Program 2003/2009 Intrum Justitia's Employee Stock Option Program 2003/2009,...

Ground breaking results for Tripep in the ongoing clinical trial of ChronVac-C® for the treatment of chronic hepatitis C Tripep can today report on preliminary results from the two first patients...

Genombrott för Tripep i pågående klinisk studie av ChronVac-C® för behandling av kronisk hepatit C Tripep kan idag rapportera om resultat från de två första patienterna i mellandosgruppen som...

Basel, 30. Juni, 2008 - Basilea Pharmaceutica AG gibt bekannt, dass Ceftobiprol (ZEFTERA(TM)), das erste anti-MRSA Breitspektrum-Antibiotikum der Cephalosporin-Klasse, von der kanadischen...

Basel, Switzerland, June 30, 2008 - Basilea Pharmaceutica Ltd. announces that ceftobiprole (ZEFTERA(TM)), the first-in-class anti-MRSA broad-spectrum cephalosporin, has obtained regulatory approval...

ADVA OPTICAL NETWORKING KORRIGIERT SEINE UMSATZ- UND ERGEBNISPROGNOSE FÜR Q2 2008   Umsatzerwartung für Q2 2008 zwischen EUR 50 Millionen und EUR 52 Millionen, geringer als...

ADVA OPTICAL NETWORKING ADJUSTS q2 2008 REVENUE AND PROFITABILITY GUIDANCE   Q2 2008 revenues forecasted to be between EUR 50 million and EUR 52 million, down from previous...

NunaMinerals share capital is now DKK 106.621.600 Announcement is given in attached file. ...